Adagrasib

http://dbpedia.org/resource/Adagrasib an entity of type: Thing

Adagrasib (INN, codenamed MRTX-849), is an experimental cancer drug being developed by Mirati Therapeutics. It acts as a covalently binding inhibitor for a mutant form of the protein KRAS called G12C, which is commonly present in various forms of cancer and acts as a growth factor. It has shown promising results in pre-clinical testing and is currently in clinical trials. rdf:langString
rdf:langString Adagrasib
xsd:integer 67027951
xsd:integer 1116636629
rdf:langString None
xsd:integer 32
xsd:integer 2326521
xsd:integer 1
rdf:langString DB15568
xsd:integer 1
xsd:integer 35
rdf:langString {-4-[7--2-{[-1methylpyrrolidin-2-yl]methoxy}-5,6,7,8tetrahydropyrido[3,4-d]pyrimidin-4-yl]-1-piperazin-2-yl}acetonitrile
rdf:langString D12301
xsd:integer 7
xsd:integer 2
xsd:integer 138611145
rdf:langString CN1CCC[C@H]1COC2=NC3=CCN6CCNCCF
xsd:integer 1
rdf:langString PEMUGDMSUDYLHU-ZEQRLZLVSA-N
xsd:integer 8
rdf:langString Adagrasib (INN, codenamed MRTX-849), is an experimental cancer drug being developed by Mirati Therapeutics. It acts as a covalently binding inhibitor for a mutant form of the protein KRAS called G12C, which is commonly present in various forms of cancer and acts as a growth factor. It has shown promising results in pre-clinical testing and is currently in clinical trials.
xsd:nonNegativeInteger 5376
xsd:string 2326521-71-3
xsd:string DB15568
xsd:string 8EOO6HQF8Y
xsd:string D12301
xsd:string 138611145

data from the linked data cloud